Stockreport

Insider Spends US$395k Buying More Shares In Relmada Therapeutics [Yahoo! Finance]

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com
PDF NASDAQ:RLMD ) shareholders may wish to note that the CEO & Director, Sergio Traversa, recently bought US$395k worth of stock, paying US$2.82 for each share. That certain [Read more]